Tianjin Medical University Cancer Institute And Hospital
Clinical trials sponsored by Tianjin Medical University Cancer Institute And Hospital, explained in plain language.
-
Double-Dose drug combo tested for Tough-to-Treat lung cancer
Disease control CompletedThis study tested whether combining two existing cancer drugs—bevacizumab and a double dose of icotinib—works better than standard treatment for people with advanced non-small cell lung cancer that has a specific genetic change (EGFR L858R mutation). The trial involved 35 adults …
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for young women with stubborn breast cancer
Disease control CompletedThis study tested whether adding a drug called darsilide to standard hormone therapy could help shrink tumors in premenopausal women with a specific type of breast cancer. The trial involved 119 women whose cancer hadn't responded well to initial chemotherapy. Researchers measure…
Phase: PHASE2, PHASE3 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
AI takes on cancer: can computers outdraw doctors for safer radiation?
Diagnosis CompletedThis study tested whether new AI software could help doctors plan radiation therapy for lung, breast, and esophageal cancer more quickly and accurately. Researchers compared three methods for outlining organs on patient CT scans: doctors drawing by hand, the AI drawing alone, and…
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC
-
New stomach cancer test aims to predict disease spread before surgery
Diagnosis CompletedThis study tested a new scoring model designed to predict whether a patient's stomach cancer has spread to their lymph nodes before they have surgery. Doctors followed 120 patients who had surgery for stomach cancer to see if the model's predictions matched what was found during …
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Diagnosis
Last updated Mar 10, 2026 12:53 UTC
-
Could a simple food blend ease a harsh side effect of cancer treatment?
Symptom relief CompletedThis study tested whether a concentrated supplement made from common foods like taro and rice could help control diarrhea caused by chemotherapy. It involved 30 adults with stomach or colorectal cancer who were experiencing this side effect. The goal was to see if adding this die…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Doctors test new tool to predict cancer spread after surgery
Knowledge-focused CompletedThis study tested a tool designed to predict which stomach cancer patients are at higher risk of the cancer spreading to their liver after surgery. Researchers followed 120 patients who had their stomach tumor removed to see if the tool's predictions matched what actually happene…
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC